![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Assurgen Pharma Pvt Ltd Visakhapatnam In, based in India, is a pharmaceutical company.
One of their significant offerings is Pantoprazole sodium sesquihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2018-199 - Rev 00
This Chemical Type CEP, issued on April 16, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2296 associated with this CEP further emphasizes